BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 34426119)

  • 21. Oleate activates SREBP-1 signaling activity in
    Lounis MA; Bergeron KF; Burhans MS; Ntambi JM; Mounier C
    Am J Physiol Endocrinol Metab; 2017 Dec; 313(6):E710-E720. PubMed ID: 28851735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pistachio Consumption Prevents and Improves Lipid Dysmetabolism by Reducing the Lipid Metabolizing Gene Expression in Diet-Induced Obese Mice.
    Terzo S; Caldara GF; Ferrantelli V; Puleio R; Cassata G; Mulè F; Amato A
    Nutrients; 2018 Dec; 10(12):. PubMed ID: 30513740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-hepatic steatosis activity of Sicyos angulatus extract in high-fat diet-fed mice and chemical profiling study using UHPLC-qTOF-MS/MS spectrometry.
    An JP; Choi JH; Huh J; Lee HJ; Han S; Noh JR; Kim YH; Lee CH; Oh WK
    Phytomedicine; 2019 Oct; 63():152999. PubMed ID: 31280138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chinese herbal medicine mixture 919 syrup alleviates nonalcoholic fatty liver disease in rats by inhibiting the NF-κB pathway.
    Chen M; Xing J; Pan D; Peng X; Gao P
    Biomed Pharmacother; 2020 Aug; 128():110286. PubMed ID: 32521450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ginger Essential Oil Ameliorates Hepatic Injury and Lipid Accumulation in High Fat Diet-Induced Nonalcoholic Fatty Liver Disease.
    Lai YS; Lee WC; Lin YE; Ho CT; Lu KH; Lin SH; Panyod S; Chu YL; Sheen LY
    J Agric Food Chem; 2016 Mar; 64(10):2062-71. PubMed ID: 26900108
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rotundic Acid Protects against Metabolic Disturbance and Improves Gut Microbiota in Type 2 Diabetes Rats.
    Yan Z; Wu H; Yao H; Pan W; Su M; Chen T; Su W; Wang Y
    Nutrients; 2019 Dec; 12(1):. PubMed ID: 31887996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of SREBP-1c ameliorates iron-induced liver fibrosis by decreasing lipocalin-2.
    Lee EH; Lee JH; Kim DY; Lee YS; Jo Y; Dao T; Kim KE; Song DK; Seo JH; Seo YK; Seong JK; Moon C; Han E; Kim MK; Ryu S; Shin M; Roh GS; Jung HR; Osborne TF; Ryu D; Jeon TI; Im SS
    Exp Mol Med; 2024 Apr; 56(4):1001-1012. PubMed ID: 38622198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phloridzin Ameliorates Lipid Deposition in High-Fat-Diet-Fed Mice with Nonalcoholic Fatty Liver Disease
    Liu H; Chen Y; Wen Y; Zhu S; Huang S; He L; Hou S; Lai X; Chen S; Dai Z; Liang J
    J Agric Food Chem; 2021 Aug; 69(31):8671-8683. PubMed ID: 34342231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel hepatoprotective role of Leonurine hydrochloride against experimental non-alcoholic steatohepatitis mediated via AMPK/SREBP1 signaling pathway.
    Zhang L; Li HX; Pan WS; Khan FU; Qian C; Qi-Li FR; Xu X
    Biomed Pharmacother; 2019 Feb; 110():571-581. PubMed ID: 30537674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genipin alleviates high-fat diet-induced hyperlipidemia and hepatic lipid accumulation in mice via miR-142a-5p/SREBP-1c axis.
    Zhong H; Chen K; Feng M; Shao W; Wu J; Chen K; Liang T; Liu C
    FEBS J; 2018 Feb; 285(3):501-517. PubMed ID: 29197188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Betulinic acid alleviates non-alcoholic fatty liver by inhibiting SREBP1 activity via the AMPK-mTOR-SREBP signaling pathway.
    Quan HY; Kim DY; Kim SJ; Jo HK; Kim GW; Chung SH
    Biochem Pharmacol; 2013 May; 85(9):1330-40. PubMed ID: 23435355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antrodan Alleviates High-Fat and High-Fructose Diet-Induced Fatty Liver Disease in C57BL/6 Mice Model via AMPK/Sirt1/SREBP-1c/PPARγ Pathway.
    Chyau CC; Wang HF; Zhang WJ; Chen CC; Huang SH; Chang CC; Peng RY
    Int J Mol Sci; 2020 Jan; 21(1):. PubMed ID: 31935815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carnosic acid protects mice from high-fat diet-induced NAFLD by regulating MARCKS.
    Song HM; Li X; Liu YY; Lu WP; Cui ZH; Zhou L; Yao D; Zhang HM
    Int J Mol Med; 2018 Jul; 42(1):193-207. PubMed ID: 29620148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CGplus, a standardized herbal composition ameliorates non-alcoholic steatohepatitis in a tunicamycin-induced mouse model.
    Lee MM; Kim HG; Lee SB; Lee JS; Kim WY; Choi SH; Lee SK; Byun CK; Hyun PM; Son CG
    Phytomedicine; 2018 Mar; 41():24-32. PubMed ID: 29519316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Esculin protects against methionine choline-deficient diet-induced non-alcoholic steatohepatitis by regulating the Sirt1/NF-
    Yang XD; Chen Z; Ye L; Chen J; Yang YY
    Pharm Biol; 2021 Dec; 59(1):922-932. PubMed ID: 34243681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oleic acid protects saturated fatty acid mediated lipotoxicity in hepatocytes and rat of non-alcoholic steatohepatitis.
    Chen X; Li L; Liu X; Luo R; Liao G; Li L; Liu J; Cheng J; Lu Y; Chen Y
    Life Sci; 2018 Jun; 203():291-304. PubMed ID: 29709653
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of the new thiazolidine derivative LPSF/GQ-02 on hepatic lipid metabolism pathways in non-alcoholic fatty liver disease (NAFLD).
    Araújo S; Soares E Silva A; Gomes F; Ribeiro E; Oliveira W; Oliveira A; Lima I; Lima MDC; Pitta I; Peixoto C
    Eur J Pharmacol; 2016 Oct; 788():306-314. PubMed ID: 27349145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The combination of Ilexhainanoside D and ilexsaponin A
    Zhao W; Xiao M; Yang J; Zhang L; Ba Y; Xu R; Liu Z; Zou H; Yu P; Wu X; Chen X
    Phytomedicine; 2019 Oct; 63():153039. PubMed ID: 31387054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mori Cortex extract ameliorates nonalcoholic fatty liver disease (NAFLD) and insulin resistance in high-fat-diet/streptozotocin-induced type 2 diabetes in rats.
    Ma LL; Yuan YY; Zhao M; Zhou XR; Jehangir T; Wang FY; Xi Y; Bu SZ
    Chin J Nat Med; 2018 Jun; 16(6):411-417. PubMed ID: 30047462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
    Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
    Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.